Sensei Biotherapeutics enters at-the-market equity distribution agreement for up to $150 million stock sale
Toronto-Dominion Bank TD | 0.00 | |
Sensei Biotherapeutics, Inc. SNSE | 0.00 | |
Faeth Therapeutics, Inc. FTH | 0.00 |
- Sensei Biotherapeutics entered an at-the-market equity distribution agreement with TD Securities (USA) to sell up to USD 150 million of common stock.
- Agent to sell shares from time to time under company instructions; commission up to 3% of gross sales.
- Series B non-voting convertible preferred stock converted into 24,435,594 common shares; common shares outstanding rose to 25,778,754 as of June 15, 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sensei Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-276093), on June 18, 2026, and is solely responsible for the information contained therein.
